CD8A and COVID-19: In contrast to humoral immunity, the virus-specific TH1 and CD8+ T cell immune responses were rapidly induced and sustained in asymptomatic or mild symptomatic patients as compared to patients with moderate or severe disease, which presumably protect them from progressing to severe COVID-19 (Fig. 6).